CRA provided testimony on behalf of plaintiff in litigation regarding a health plan’s use of MFN clauses with hospitals. CRA identified several mechanisms by which the MFN clauses were likely to reduce competition in this matter and demonstrated that they had historically harmed competitors. CRA also analyzed whether this harm to competition was offset by the procompetitive effects of MFN clauses.
The politician and the judge: Implications for competition policy
Drawing on the historical evolution of antitrust policy, the authors argue that some increase in politicisation is likely an inevitable result of the expansion...